Tandem Diabetes Care, Inc.
TNDM
$22.39
-$0.46-2.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 982.95M | 940.20M | 854.35M | 796.00M | 770.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 982.95M | 940.20M | 854.35M | 796.00M | 770.01M |
| Cost of Revenue | 469.64M | 450.63M | 428.94M | 405.49M | 390.55M |
| Gross Profit | 513.31M | 489.57M | 425.41M | 390.51M | 379.46M |
| SG&A Expenses | 404.68M | 389.82M | 371.84M | 351.53M | 340.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.07B | 1.04B | 990.06M | 937.16M | 905.10M |
| Operating Income | -91.94M | -99.13M | -135.70M | -141.16M | -135.09M |
| Income Before Tax | -174.43M | -91.87M | -123.20M | -131.31M | -136.20M |
| Income Tax Expenses | 9.44M | 4.16M | 3.59M | 5.18M | 5.26M |
| Earnings from Continuing Operations | -183.87 | -96.03 | -126.78 | -136.49 | -141.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -183.87M | -96.03M | -126.78M | -136.49M | -141.45M |
| EBIT | -91.94M | -99.13M | -135.70M | -141.16M | -135.09M |
| EBITDA | -75.07M | -82.52M | -119.31M | -124.95M | -118.73M |
| EPS Basic | -2.78 | -1.47 | -1.94 | -2.09 | -2.17 |
| Normalized Basic EPS | -0.80 | -0.83 | -1.17 | -1.25 | -1.18 |
| EPS Diluted | -2.78 | -1.47 | -1.94 | -2.09 | -2.17 |
| Normalized Diluted EPS | -0.80 | -0.83 | -1.17 | -1.25 | -1.18 |
| Average Basic Shares Outstanding | 262.88M | 261.80M | 261.23M | 260.81M | 260.64M |
| Average Diluted Shares Outstanding | 263.09M | 262.02M | 261.23M | 260.81M | 260.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |